11-46366327-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS2_Supporting
The NM_001105540.2(DGKZ):c.71G>A(p.Ser24Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,562,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001105540.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DGKZ | NM_001199267.2 | c.162-964G>A | intron_variant | ENST00000456247.7 | NP_001186196.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DGKZ | ENST00000456247.7 | c.162-964G>A | intron_variant | 1 | NM_001199267.2 | ENSP00000395684.2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000381 AC: 7AN: 183674Hom.: 0 AF XY: 0.0000489 AC XY: 5AN XY: 102172
GnomAD4 exome AF: 0.0000135 AC: 19AN: 1410090Hom.: 0 Cov.: 33 AF XY: 0.0000129 AC XY: 9AN XY: 699470
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152298Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2024 | The c.71G>A (p.S24N) alteration is located in exon 2 (coding exon 1) of the DGKZ gene. This alteration results from a G to A substitution at nucleotide position 71, causing the serine (S) at amino acid position 24 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at